Last reviewed · How we verify

NCT06577896

The Study to Evaluate the Safety and Efficacy of the Onyx Family

Recruiting now Last updated 19 September 2024
What this trial tests

trial testing Onyx family in Coronary Artery Disease in 500 participants. Currently enrolling.

Timeline
9 June 2022
Primary endpoint
31 January 2026
31 December 2026

Quick facts

Lead sponsorPusan National University Yangsan Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date9 June 2022
Primary completion31 January 2026
Estimated completion31 December 2026
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Pusan National University Yangsan Hospital

Who can join

Adults 75 to 100, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observation of the safety and efficacy of 1-month dual antiplatelet therapy (DAPT) after percutaneous coronary intervention using Onyx family stents in elderly patients aged 75 years or older

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Pusan National University Yangsan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06577896.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing